VTR - Ventas, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$99.43
DETAILS
HIGH:
$110.00
LOW:
$88.00
MEDIAN:
$100.00
CONSENSUS:
$99.43
UPSIDE:
8.06%
AlphaVal
Deterministic, archetype-aware fair value
Real Estate Investment Trust
85% confidence
Primary model: P/FFO × Healthcare REIT Multiple
Adjust Assumptions
18.9x
$
Key Value Driver
FFO/share ($3.35) × healthcare P/FFO multiple
Implied Market Multiple
27.4x
Plain-Language Summary
At $3.35 FFO/share with a 19x healthcare REIT multiple, the base-case value is $54.76 per share. Dividend yield: 2.2%. DDM cross-check: $34.79.
Analyst Consensus (External Reference)
Never blended into the bear/base/bull estimates above -- shown only as an outside comparison.
Average Target (32 analysts)
$99.43
Analyst Range
$88.00 – $110.00
Divergence from AlphaVal
45%
Warnings
Standard profit figures are misleading for real estate companies — large non-cash accounting charges make profits look artificially low. Dividend yield and funds from operations are better measures.
Dividend-based valuation: $34.79 (36% below our primary estimate). Large gaps suggest the dividend may not fully reflect the company's value.
Wall Street's average price target is $99.43 (from 32 analysts). Our estimate is 45% below the consensus -- consider that gap carefully.
Key Risks
- P/E and EV/EBITDA are structurally wrong for REITs — use P/FFO and NAV
- Interest rate sensitivity: REIT multiples compress when rates rise
- FFO approximation (NI + D&A) may include gains on property sales — verify